Shaïda Varnous
YOU?
Author Swipe
View article: What happens to patients awaiting urgent transplantation for refractory electrical storm when they are not transplanted?
What happens to patients awaiting urgent transplantation for refractory electrical storm when they are not transplanted? Open
International audience
View article: Incidence and determinants of non-radial vascular approach for coronary angiography among heart transplant recipients
Incidence and determinants of non-radial vascular approach for coronary angiography among heart transplant recipients Open
Background Repeated coronary angiograms may be required among heart transplant (HT) recipients to detect coronary allograft vasculopathy (CAV), exposing to higher risk of non-radial vascular approach over time. Objective To describe the in…
View article: Sudden cardiac death after heart transplantation: a population-based study
Sudden cardiac death after heart transplantation: a population-based study Open
Aims The epidemiology of sudden cardiac death (SCD) after heart transplantation (HTx) remains imprecisely described. We aimed to assess the incidence and determinants of SCD in a large cohort of HTx recipients, compared with the general po…
View article: Association between vasoactive–inotropic score, morbidity and mortality after heart transplantation
Association between vasoactive–inotropic score, morbidity and mortality after heart transplantation Open
OBJECTIVES The aim of this study was to evaluate the association between vasoactive–inotropic score (VIS), calculated in the 24 h after heart transplantation, and post-transplant mortality and morbidity. METHODS This was an observational s…
View article: Severity of SARS-CoV-2 Omicron variant infection in heart transplant recipients
Severity of SARS-CoV-2 Omicron variant infection in heart transplant recipients Open
View article: Clinical Prediction Model for Antibody-Mediated Rejection: A Strategy to Minimize Surveillance Endomyocardial Biopsies After Heart Transplantation
Clinical Prediction Model for Antibody-Mediated Rejection: A Strategy to Minimize Surveillance Endomyocardial Biopsies After Heart Transplantation Open
Background: In heart transplantation, antibody-mediated rejection (AMR) is a major contributor to patient morbidity and mortality. Multiple routine endomyocardial biopsies (EMB) remain the gold standard to detect AMR, but this invasive pro…
View article: Impact of Sex in the Efficacy of Perioperative Desensitization Procedures in Heart Transplantation: A Retrospective Cohort Study
Impact of Sex in the Efficacy of Perioperative Desensitization Procedures in Heart Transplantation: A Retrospective Cohort Study Open
Background Sensitized patients, i.e. recipients with preformed donor-specific HLA antibodies (pfDSA), are at high-risk of developing antibody-mediated rejections (AMR) and dying after heart transplantation (HTx). Perioperative desensitizat…
View article: Poor Antibody Response After Two Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine in Transplant Recipients
Poor Antibody Response After Two Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine in Transplant Recipients Open
A low anti-spike antibody response of 28.6% was observed 28 days after BNT162b2 vaccine second dose among 133 solid organ transplant recipients without previous coronavirus disease 2019 (COVID-19). No serious adverse events were recorded. …
View article: Death Rate in Heart Transplant Recipients during the COVID-19 Outbreak in France
Death Rate in Heart Transplant Recipients during the COVID-19 Outbreak in France Open
View article: Clinical manifestations and outcomes of coronavirus disease‐19 in heart transplant recipients: a multicentre case series with a systematic review and meta‐analysis
Clinical manifestations and outcomes of coronavirus disease‐19 in heart transplant recipients: a multicentre case series with a systematic review and meta‐analysis Open
Available data on clinical presentation and mortality of coronavirus disease-2019 (COVID-19) in heart transplant (HT) recipients remain limited. We report a case series of laboratory-confirmed COVID-19 in 39 HT recipients from 3 French hea…
View article: Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation and association with mortality: a population-based study
Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation and association with mortality: a population-based study Open
Background Cardiac allograft vasculopathy (CAV) is a major contributor of heart transplant recipient's mortality. However, the associations between CAV trajectories and mortality remains poorly described. Purpose We aimed to identify the d…
View article: Incidence of sudden cardiac death after heart transplantation
Incidence of sudden cardiac death after heart transplantation Open
Background Sudden cardiac death (SCD) is a major contributor to the rate of mortality after heart transplantation. However, little is known about the incidence of SCD in heart recipients. Objective To assess the incidence of SCD after hear…
View article: Identification and Characterization of Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation
Identification and Characterization of Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation Open
Background: Cardiac allograft vasculopathy (CAV) is a major contributor of heart transplant recipient mortality. Little is known about the prototypes of CAV trajectories at the population level. We aimed to identify the different evolution…
View article: Quadritherapy vs standard tritherapy immunosuppressant regimen after heart transplantation: A propensity score–matched cohort analysis
Quadritherapy vs standard tritherapy immunosuppressant regimen after heart transplantation: A propensity score–matched cohort analysis Open
After heart transplant, adding everolimus (EVL) to standard immunosuppressive regimen mostly relies on converting calcineurin inhibitors (CNIs) into EVL. The aim of this study was to describe the effects of combining low-dose EVL and CNIs …
View article: Predictive risk factors for postoperative pneumonia after heart transplantation
Predictive risk factors for postoperative pneumonia after heart transplantation Open
View article: Predictive risk factors for postoperative pneumonia after heart transplantation
Predictive risk factors for postoperative pneumonia after heart transplantation Open
Background: Pneumonia is a frequent complication in patients undergoing heart transplantation (HTx) that increases morbidity and mortality in this population. Nevertheless, the risk factors for postoperative pneumonia (POP) are still unkno…
View article: Reverse transcriptase multiplex ligation-dependent probe amplification in endomyocardial biopsies for the diagnosis of cardiac allograft rejection
Reverse transcriptase multiplex ligation-dependent probe amplification in endomyocardial biopsies for the diagnosis of cardiac allograft rejection Open
View article: Predictive risk factors of postoperative pneumonia after heart transplantation
Predictive risk factors of postoperative pneumonia after heart transplantation Open
Background Pneumonia is a frequent complication in patients undergoing heart transplantation (HTx) which increases morbidity and mortality in this population. Nevertheless, risk factors of postoperative pneumonia (POP) are still unknown. T…
View article: Favorable Outcome of an Exclusively Posttransplant Prophylactic Strategy After Heart Transplantation in Recipients With High Immunological Risk
Favorable Outcome of an Exclusively Posttransplant Prophylactic Strategy After Heart Transplantation in Recipients With High Immunological Risk Open
Background. Management of the increasing number of sensitized heart transplant candidates has become a recurrent issue. Rather than using pretransplant desensitization therapies, we used a posttransplant prophylactic strategy. Our aim was …
View article: Effect of recipient gender and donor-specific antibodies on antibody-mediated rejection after heart transplantation
Effect of recipient gender and donor-specific antibodies on antibody-mediated rejection after heart transplantation Open
Gender-difference regarding antibody-mediated rejection (AMR) after heart transplantation has been described. However, no study accounted for the presence of preformed donor-specific antibodies (pfDSA), a known risk factor of AMR, more com…
View article: 3399Determinants and outcomes of cardiac allograft vasculopathy: major role of donor specific antibody
3399Determinants and outcomes of cardiac allograft vasculopathy: major role of donor specific antibody Open
Background: Neutrophils are able to release their nuclear content into extracellular space by formation of neutrophil extracellular traps (NETs).NETs neutralize pathogens, but have also been implicated in autoimmune and thrombotic diseases…
View article: P4222Pre-heart transplantation ECMO support achieved favorable post-transplant outcomes in selected patients
P4222Pre-heart transplantation ECMO support achieved favorable post-transplant outcomes in selected patients Open
Purpose: To evaluate the usefulness of T. cruzi parasitic load (PL) quantitation in EMB for the early detection of CDR affecting the allograft.Methods: CDR was diagnosed in 8 heart-transplanted, chagasic patients (T.cruzi parasites detecte…
View article: N-acetyl cysteine alleviates oxidative stress and protects mice from dilated cardiomyopathy caused by mutations in nuclear A-type lamins gene
N-acetyl cysteine alleviates oxidative stress and protects mice from dilated cardiomyopathy caused by mutations in nuclear A-type lamins gene Open
Cardiomyopathy caused by lamin A/C gene (LMNA) mutations (hereafter referred as LMNA cardiomyopathy) is an anatomic and pathologic condition associated with muscular and electrical dysfunction of the heart, often leading to heart failure-r…
View article: Performance of existing risk scores around heart transplantation: validation study in a 4-year cohort
Performance of existing risk scores around heart transplantation: validation study in a 4-year cohort Open
Several risk scores exist to help identify best candidate recipients for heart transplantation (HTx). This study describes the performance of five heart failure risk scores and two post-HTx mortality risk scores in a French single-centre c…
View article: Heart Transplantation for Peripartum Cardiomyopathy: A Single-Center Experience
Heart Transplantation for Peripartum Cardiomyopathy: A Single-Center Experience Open
Background: Peripartum cardiomyopathy is an idiopathic disorder defined by the occurrence of acute heart failure during late pregnancy or post-partum period in the absence of any other definable cause. Its clinical course is variable and s…
View article: Heart Transplantation for Peripartum Cardiomyopathy: A Single-Center Experience
Heart Transplantation for Peripartum Cardiomyopathy: A Single-Center Experience Open
Long-term outcomes following HT for PPCM are favorable. Heart transplantation is a valuable option for PPCM patients who did not recover significantly under medical treatment.
View article: Heart Transplantation for Peripartum Cardiomyopathy: A Single-Center Experience
Heart Transplantation for Peripartum Cardiomyopathy: A Single-Center Experience Open
Background: Peripartum cardiomyopathy is an idiopathic disorder defined by the occurrence of acute heart failure during late pregnancy or post-partum period in the absence of any other definable cause. Its clinical course is variable and s…
View article: Reply to the Editor—Rhythmologic Challenges Following Heart Transplantation
Reply to the Editor—Rhythmologic Challenges Following Heart Transplantation Open
View article: P2084Multi-layer longitudinal strain for noninvasive diagnosis of coronary allograft vasculopathy in heart transplant recipients: a comparative study ultrasound versus angiography
P2084Multi-layer longitudinal strain for noninvasive diagnosis of coronary allograft vasculopathy in heart transplant recipients: a comparative study ultrasound versus angiography Open
View article: Management of end-stage heart failure patients with or without ventricular assist device: an observational comparison of clinical and economic outcomes†
Management of end-stage heart failure patients with or without ventricular assist device: an observational comparison of clinical and economic outcomes† Open
HT should remain the first option for end-stage heart failure patients, associated with improved outcomes and better cost-effectiveness profile. VAD devices represent an option when transplant is not possible or when patient presentation i…